IMNM vs NTAP · $2.47B cap vs P/E 28, rev $6.24B
Immunome Inc (IMNM) versus NetApp Inc (NTAP) — a side-by-side from cached financials, not a winner call.
Immunome Inc (IMNM) is a biotechnology company listed on US.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
IMNM currently screens at market cap $2.47B. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Not investment advice. Open the IMNM and NTAP stock pages for the full models.
Not investment advice.